News | September 21, 2012

RadNet Joins GE Healthcare to Evaluate Breast Cancer Detection Processes

Study to evaluate model for improving the efficiency of the breast cancer detection process in the clinical practice setting

GE Healthcare RadNet Women's Healthcare Mammography Systems

September 21, 2012—GE Healthcare, a business division of General Electric Company, announced it is joining with RadNet, a network of outpatient diagnostic imaging centers, to pilot its Best Pathways initiative, a breast cancer detection optimization model. GE Healthcare and RadNet will evaluate the clinical breast cancer detection process to quantify inefficient diagnostic patterns and identify optimal paths to lower cost and improve patient outcomes. This program will focus on subpopulations of women in which guidelines are lacking and substantial variability is observed in clinical practice.

Best Pathways is designed to address a significant need for increased insight into the breast cancer detection process--from a patient’s initial screening mammogram to final biopsy. Historically, diagnostic processes have been variable and inefficient, leading to frequent false-positive test results and costly follow-up imaging procedures. In 2009, the U.S. Preventative Services Task Force (USPSTF) tightened recommendations for breast cancer screenings across multiple patient populations, citing lack of evidence supporting benefits and high cost of the screenings as primary factors.

“This initiative will provide deeper understanding of care patterns and ways to optimize processes to ensure the best outcomes for patients and operational efficiency for providers,” said Dr. Howard Berger, president and chief executive officer (CEO), RadNet. “With the technological and process expertise that GE Healthcare offers, as well as our shared passion for improving access to low-cost healthcare solutions, we look forward to improving care protocols in the detection of breast cancer.”

GE Healthcare and RadNet will identify and quantify diagnostic costs per cancer detected, the types of breast cancer detected and their stage distribution, the number of imaging tests and biopsies required to detect each cancer and the incremental cost-effectiveness ratios for each diagnostic case. Diagnostic patterns will be identified based on patient population characteristics including age, risk of developing breast cancer and breast density. The program will also seek to define optimal diagnostic paths for patient care based on rigorous data and analysis.

“Improving efficiency and outcomes in breast cancer detection supports our healthymagination commitment to delivering high-quality healthcare at a lower cost,” said David Lee, head of Health Economics and Reimbursement for GE Healthcare in the US and Canada. “We are pleased to work with RadNet to pilot our breast cancer detection optimization model in the clinical setting and look forward to identifying opportunities to improve the diagnosis and treatment of breast cancer while increasing efficiency and cost savings.”

GE Healthcare’s Best Pathways initiative was developed in collaboration with academic and community mammographers, primary care physicians and breast surgeons to explore alternative detection strategies and understand the need for new diagnostic technologies. Through its participation and eventual findings to be released publicly, RadNet will be able to refine and customize its breast cancer detection processes for its imaging centers for improved efficiency and better patient care.

For more information: www.radnet.com

 

 

Related Content

Videos | Mammography | December 10, 2018
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, and attending radiol
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
GE Healthcare Introduces Invenia ABUS 2.0
Technology | Ultrasound Women's Health | December 03, 2018
GE Healthcare recently launched the Invenia automated breast ultrasound (ABUS) 2.0 system in the United States. This...
Snoring Poses Greater Cardiac Risk to Women
News | Women's Health | November 29, 2018
Obstructive sleep apnea (OSA) and snoring may lead to earlier impairment of cardiac function in women than in men,...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Women Benefit From Mammography Screening Beyond Age 75
News | Mammography | November 26, 2018
Women age 75 years and older should continue to get screening mammograms because of the comparatively high incidence of...
Arterys Demonstrates AI Cloud-Based Medical Image Analysis Solutions at RSNA 2018
News | Computer-Aided Detection Software | November 26, 2018
Medical imaging software company Arterys will demonstrate its wide-ranging suite of artificial intelligence (AI)-...
Novarad Debuts NovaMG-Pro Mammography Software at RSNA 2018
News | Mammography Reporting Software | November 25, 2018
Novarad Corp. announced new mammography software NovaMG-Pro, specifically for multimodality radiologists that read...